Advertisement
U.S. markets close in 6 hours 16 minutes

Can-Fite BioPharma Ltd. (CANF)

NYSE American - NYSE American Delayed Price. Currency in USD
2.26000.0000 (0.00%)
As of 03:59PM EDT. Market open.
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts2022
Avg. Estimate-0.260-1.3-0.28
Low Estimate-0.370-1.85-0.54
High Estimate-0.160-0.75-0.03
Year Ago EPS-1.11-0.65-3.74-1.3
Revenue EstimateCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
No. of Analysts2022
Avg. Estimate100kN/A690k5M
Low EstimateN/AN/A590kN/A
High Estimate200kN/A800k10M
Year Ago Sales197kN/A810k690k
Sales Growth (year/est)-49.20%N/A-14.80%624.60%
Earnings History12/30/20223/30/20236/29/20239/29/2023
EPS Est.-0.98-1.52-0.42-0.44
EPS Actual-1.11-0.65-0.42-0.44
Difference-0.130.8700
Surprise %-13.30%57.20%0.00%0.00%
EPS TrendCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Current Estimate-0.260-1.3-0.28
7 Days Ago-0.260-1.3-0.28
30 Days Ago-0.260-1.3-0.28
60 Days Ago-0.160-0.75-0.54
90 Days Ago-0.160-0.75-0.54
EPS RevisionsCurrent Qtr. (Dec 2023)Next Qtr. (Mar 2024)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCANFIndustrySector(s)S&P 500
Current Qtr.76.60%N/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current Year65.20%N/AN/AN/A
Next Year78.50%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A